155 related articles for article (PubMed ID: 19370749)
1. Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers.
Wang SH; Shi X; Chen X; Baker JR
Macromol Biosci; 2009 May; 9(5):429-36. PubMed ID: 19370749
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of submicrometer-sized 2-methoxyestradiol crystals into polymer multilayer capsules for biological applications.
Shi X; Wang S; Chen X; Meshinchi S; Baker JR
Mol Pharm; 2006; 3(2):144-51. PubMed ID: 16579643
[TBL] [Abstract][Full Text] [Related]
3. Impact of polyelectrolytes and their corresponding multilayers to human primary endothelial cells.
Nolte A; Hossfeld S; Schroeppel B; Mueller A; Stoll D; Walker T; Wendel HP; Krastev R
J Biomater Appl; 2013 Jul; 28(1):84-99. PubMed ID: 22457040
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimitotic activity of novel 2-methoxyestradiol analogs.
Rao PN; Cessac JW; Tinley TL; Mooberry SL
Steroids; 2002 Dec; 67(13-14):1079-89. PubMed ID: 12441194
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
Verenich S; Gerk PM
Mol Pharm; 2010 Dec; 7(6):2030-9. PubMed ID: 20831190
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle multilayers: surface modification of photosensitive drug microparticles for increased stability and in vitro bioavailability.
Li N; Kommireddy DS; Lvov Y; Liebenberg W; Tiedt LR; De Villiers MM
J Nanosci Nanotechnol; 2006; 6(9-10):3252-60. PubMed ID: 17048544
[TBL] [Abstract][Full Text] [Related]
7. Thin films of polyelectrolyte-encapsulated catalase microcrystals for biosensing.
Yu A; Caruso F
Anal Chem; 2003 Jul; 75(13):3031-7. PubMed ID: 12964747
[TBL] [Abstract][Full Text] [Related]
8. Bioinspired Titanium Drug Eluting Platforms Based on a Poly-β-cyclodextrin-Chitosan Layer-by-Layer Self-Assembly Targeting Infections.
Pérez-Anes A; Gargouri M; Laure W; Van Den Berghe H; Courcot E; Sobocinski J; Tabary N; Chai F; Blach JF; Addad A; Woisel P; Douroumis D; Martel B; Blanchemain N; Lyskawa J
ACS Appl Mater Interfaces; 2015 Jun; 7(23):12882-93. PubMed ID: 25992843
[TBL] [Abstract][Full Text] [Related]
9. Microstructuring of polyelectrolyte coated surfaces for directing capsule adhesion.
Nolte M; Fery A
IEEE Trans Nanobioscience; 2004 Mar; 3(1):22-6. PubMed ID: 15382639
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol.
Solum EJ; Akselsen ØW; Vik A; Hansen TV
Curr Pharm Des; 2015; 21(38):5453-66. PubMed ID: 26429718
[TBL] [Abstract][Full Text] [Related]
11. PEG-PCL modification and intestinal sustained-release of solid lipid nanoparticles for improving oral bioavailability of 2-methoxyestradiol.
Xing Y; Liu X; Li X; Ding F; Zhang J; Guo X
J Liposome Res; 2019 Sep; 29(3):207-214. PubMed ID: 30280943
[TBL] [Abstract][Full Text] [Related]
12. Novel formulations of vitamins and insulin by nanoengineering of polyelectrolyte multilayers around microcrystals.
Dai Z; Heilig A; Zastrow H; Donath E; Möhwald H
Chemistry; 2004 Dec; 10(24):6369-74. PubMed ID: 15532049
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS
Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471
[TBL] [Abstract][Full Text] [Related]
14. Effect of 2-methoxyestradiol, buthionine sulfoximine and hydrogen peroxide on the viability of renal carcinoma cell lines (ACHN and ACVB).
Hirai Y; Kawabe N; Tsuda Y; Miyamoto S; Iwakawa S
Biol Pharm Bull; 2006 May; 29(5):1064-7. PubMed ID: 16651749
[TBL] [Abstract][Full Text] [Related]
15. Novel p-carborane-containing multitarget anticancer agents inspired by the metabolism of 17β-estradiol.
Kaise A; Ohta K; Endo Y
Bioorg Med Chem; 2017 Dec; 25(24):6371-6378. PubMed ID: 29054710
[TBL] [Abstract][Full Text] [Related]
16. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells.
Maran A; Dadsetan M; Buenz CM; Shogren KL; Lu L; Yaszemski MJ
J Biomed Mater Res A; 2013 Sep; 101(9):2491-9. PubMed ID: 23355512
[TBL] [Abstract][Full Text] [Related]
17. Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogel.
Cho JK; Hong KY; Park JW; Yang HK; Song SC
J Drug Target; 2011 May; 19(4):270-80. PubMed ID: 20608785
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nitric oxide synthase induction in the antitumorigenic and neurotoxic effects of 2-methoxyestradiol.
Gorska M; Kuban-Jankowska A; Zmijewski MA; Gorzynik M; Szkatula M; Wozniak M
Molecules; 2014 Aug; 19(9):13267-81. PubMed ID: 25170949
[TBL] [Abstract][Full Text] [Related]
19. Combination of 2-methoxyestradiol (2-ME2) and eugenol for apoptosis induction synergistically in androgen independent prostate cancer cells.
Ghosh R; Ganapathy M; Alworth WL; Chan DC; Kumar AP
J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):25-35. PubMed ID: 19084597
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol Affects Mitochondrial Biogenesis Pathway and Succinate Dehydrogenase Complex Flavoprotein Subunit A in Osteosarcoma Cancer Cells.
Gorska-Ponikowska M; Kuban-Jankowska A; Eisler SA; Perricone U; Lo Bosco G; Barone G; Nussberger S
Cancer Genomics Proteomics; 2018; 15(1):73-89. PubMed ID: 29275365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
